The evaluation of clinical results of hepatic artery embolization

The clinical symptoms and liver function following hepatic artery embolization (h.a.e.) in patients with inoperable liver neoplasms were evaluated. The study was performed on 28 patients 11 of whom were male in the age of 53-72 years and 17 female aged 16-76. Before embolization liver function was evaluated on the basis of clinical data and laboratory tests. Transcatheter hepatic artery embolization was performed using Spongostan. Following h.a.e. clinical status and biochemical analysis of blood and urine were checked repeatedly. Twenty-two patients developed post embolization syndrome dominated by: epigastric pain, nausea, and vomiting. Fourteen patients and disturbed intestinal motoric. All those symptoms were transient and lasted 1-3 days. Elevated body temperature was observed in 14 patients. There was a statistically significant increase of ALAT & AspAT after embolization lasting for a few days. There were however no statistically significant changes in the results of tymol test and total bilirubin level in blood.